高齢者における不適切な抗高血圧療法

Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the hispanic community health study/study of latinos.

Journal of human hypertension·2017

Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic Community Health Study/Study of Latinos.

Journal of human hypertension·2017

Parallel evolution of glucosinolate biosynthesis inferred from congruent nuclear and plastid gene phylogenies.

American journal of botany·2011

Responses to weight loss treatment among obese individuals with and without BED: a matched-study meta-analysis.

Eating and weight disorders : EWD·2007

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Annals of internal medicine·2001

Trend of stroke hospitalization, United States, 1988-1997.

Stroke·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction.

Case reports in critical care·2026

Percutaneous Thrombectomy for Clot-in-Transit With Concomitant Left Ventricular Thrombus in a Patient With Acute Heart Failure Exacerbation: A Case Report.

Cureus·2026

Recurrent Acute Limb Ischemia and Direct Oral Anticoagulant Failure: A Case of Suspected Antiphospholipid Syndrome Triggered by Mechanical Compression.

Cureus·2026

Unusual Coexistence of Takayasu Arteritis, Diffuse Coronary Aneurysms, and a Large Left Atrial Myxoma in an Elderly Male: A Case Report and Literature Review.

Cureus·2026

Remimazolam-based anesthesia in sepsis patients: a retrospective cohort study of hemodynamic stability and postoperative outcomes.

Frontiers in medicine·2026

Impact of reperfusion on thrombectomy outcomes in patients with pre-stroke disability.

Frontiers in neurology·2026

関連する実験動画

高齢者における不適切な抗高血圧療法

関連する概念動画

Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the hispanic community health study/study of latinos.

Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic Community Health Study/Study of Latinos.

Parallel evolution of glucosinolate biosynthesis inferred from congruent nuclear and plastid gene phylogenies.

Responses to weight loss treatment among obese individuals with and without BED: a matched-study meta-analysis.

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Trend of stroke hospitalization, United States, 1988-1997.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction.

Percutaneous Thrombectomy for Clot-in-Transit With Concomitant Left Ventricular Thrombus in a Patient With Acute Heart Failure Exacerbation: A Case Report.

Recurrent Acute Limb Ischemia and Direct Oral Anticoagulant Failure: A Case of Suspected Antiphospholipid Syndrome Triggered by Mechanical Compression.

Unusual Coexistence of Takayasu Arteritis, Diffuse Coronary Aneurysms, and a Large Left Atrial Myxoma in an Elderly Male: A Case Report and Literature Review.

Remimazolam-based anesthesia in sepsis patients: a retrospective cohort study of hemodynamic stability and postoperative outcomes.

Impact of reperfusion on thrombectomy outcomes in patients with pre-stroke disability.

関連する実験動画

高齢者における不適切な抗高血圧療法

関連する概念動画

関連記事